700 JOURNAL OF CHEMICAL RESEARCH 2008
time
(h)
1,3 and 5-7
R
Yield of3 (%)
I
C6HS-
28
30
24
34
48
80
83
86
72
62
a
b
c
d
e
4-HO-C6H4-
4-CH3O-C6H4-
4-Br-C6H4-CHr
CH3
Ph
CH3CN, reflux
•
1- 2 d
Ph
Scheme
1
Reaction of N-substituted-hydrazino-carbothioimides
1a-e with 1.4-diphenylbut-2-yne-1.4-dione
(2).
126.2, 126.0 (meta-Ar 2CH), 125.2 (CH-5), 125.0, 124.8 (para-
Ar CH), 120.6 (meta-Ar 2CH). IR (KBr): vmax = 3490 (s, OH),
3330 (m, NH), 3096-3012 (m, Ar-CH), 1700 (s, COPh), 1680 (s,
CONH-), 1610 (s, C=N), 1596 (m, C=C), 1450 (s), 1118(m, C-S), em-I.
A.max (CH3CN, 19 e, urn): 375 (3.6). MS (EI): m/z (%) = 428
[M + 1] (38), 427 [W] (100), 411 (18), 335 (22), 322 (28), 246
(18), 220 (34), 216 (26), 208 (30), 120 (34), 104 (44), 76 (32).
C24H17N303S(427.49): Ca1cd C, 67.43; H, 4.01; N, 9.83; S, 7.50%.
Found C, 67.28; H, 3.94; N, 9.80; S, 7.46%.
Experimental
All melting points were recorded on a Gallenkamp apparatus.
IH NMR and BC NMR spectra (Broker AM 400, IH: 400.13 MHz,
BC: 100.6 MHz); s = singlet, d = doublet, dd = double-doublet
and m = multiplet. The NMR samples were dissolved in DMSO-d6
and/or CDC13 solutions. Coupling constants were expressed in Hz.
Elemental analyses were carried at the Cairo Microanalysis Centre of
Cairo University. Mass spectroscopy was performed with a Finnigan
MAT 8430 spectrometer at 70 eV, Institute of Organic Chemistry,
Technical University-Braunschweig, Germany. IR spectra were run
on a Shimadzu 470 spectrometer using KBr pellets.
N' -(6-Benzayl-4-phenyl- 2H-I, 3-thiazin- 2-ylidene )-( 4'-methaxy-
phenyl)hydrazide (3c): Yellow crystals (0.76 g, 86%), m.p. 210°C
(acetonitrile). IH NMR (400 MHz, CDCI3):
~ = 8.17-8.10 (dd,
Starting
materials:
N-Substituted-hydrazino-carbothioamides
2 H, J = 7.8, 1.0 Hz, ArH), 7.68-7.48 (m, 5 H, ArH), 7.36--7.22 (m,
5 H, ArH), 7.10 (s, 1 H, H-5), 6.80-6.75 (dd, 2 H, J= 8.0,1.0 Hz,
ArH), 6.70 (s, 1 H, NH-N), 3.95 (s, 3 H, OCH3). BC NMR (100.6
MHz, CDCI3): Be= 186.4 (COPh), 168.0 (CONH), 163.2 (C-4), 158.6
(C-2), 153.8 (H3CO-Ar-C), 134.0 (Ph-C), 132.4 (C-6), 132.4, 132.0
(Ph-C), 128.6, 127.2, 127.0 (artha-2Ar CH), 126.2, 125.4 (meta-Ar
2CH), 125.3 (C-5), 124.6, 124.2 (para-Ar CH), 122.6 (meta-Ar 2CH),
52.0 (OCH3). IR (KBr): vmax = 3330 (m, NH), 3070-3010 (w,Ar-CH),
2996--2880 (m, aliph.-CH), 1700 (s, COPh), 1700 (s, CONH), 1612
(s, C=N), 1590 (s, C=C), 1452 (s), 1122 (m, C-S) em-I. A.",ax (CH3CN,
19 e, urn): 382 (4.1). MS (EI): m/z (%) = 441 [M+] (100),426 (24),
410 (24), 365 (28), 336 (42),286 (32), 254 (24), 222 (34), 190 (26),
135 (42),104 (56), 77 (26). C25HI~303S (441.51): Calcd C, 68.01; H,
4.34; N, 9.52; S, 7.26%. Found C, 68.11; H, 4.28; N, 9.62; S, 7.12%.
N'-(6-Benzayl-4-phenyl-2H-I ,3-thiazin-2-ylidene)-( 4'-bromabenzyl)
hydrazide (3d): Orange crystals (0.71 g, 72%), m.p. 320°C (ethyl
acetate). IHNMR (400 MHz, DMSO-d6): BH= 7.72 (dd, dd,2H,J= 8.0,
1.0 Hz, ArH), 7.68-7.46 (m, 6 H, ArH), 7.36--7.28 (m, 4 H, ArH),
7.00 (s, 1 H, H-5), 6.80-6.65 (dd, 2 H, J = 8.0, 1.2 Hz, ArH), 6.62 (s,
1 H, NH-N), 5.10 (s, 2 H, CH2). BC NMR (100.6 MHz, DMSO-d6):
Be = 186.3 (COPh), 168.0 (CONH), 162.8 (C-4), 158.6 (C-2), 134.2
(C-6), 133.4 (artha-2Ar CH), 134.0 (ph-C), 132.0 (Br-Ar-C4'), 131.6
(Ph-C), 128.0 (Br-Ar-C), 127.6, 127.4 (artha-2Ar CH), 126.0, 125.6
(meta-Ar 2CH), 125.2 (C-5), 125.0, 124.8 (para-Ar CH), 118.8
(meta-Ar 2CH), 42.0 (CH2). IR (KBr): vmax = 3334 (m, NH), 3050-
3012 (w,Ar-CH), 2980-2860 (aliph.-CH), 1702 (s, COPh), 1684 (s,
CONH2), 1610 (s, C=N), 1592 (s, C=C), 1450 (s), 1120 (m, C-S) em-I.
A.max (CH3CN, 19e, urn): 382 (4.1). MS (EI): m/z (%) = 506 [M + 2]
(96), 504 [M+] (100), 412 (22), 429 (40), 427 (42), 426 (34), 402
(60),400 (42), 337 (26), 335 (36), 309 (18), 307 (26), 302 (22), 300
(24),272 (22), 270 (26), 226 (34), 224 (36), 186 (28), 186 (34), 184
(38), 106 (40), 104 (44), 78 (34), 76 (36). C25HISBrN302S(504.41):
Ca1cd C, 59.53; H, 3.60; Br, 15.84; N, 8.33; S, 6.36. Found C, 59.68;
H, 3.50; Br, 15.90; N, 8.40; S, 6.40%.
la-e and 1,4-diphenylbut-2-yne-l,4-dione (DBA, 2) were prepared
according to references 22 and 23, respectively.
General procedure: To a 250 cm3 two-necked round bottom flask
containing a solution ofla--e (1 mmol) in acetonitrile (100 ml) and a
solution of 2 (0.468 g, 1 mmol) in acetonitrile (30 ml) was refluxed
for 1-2 days (the reaction was monitored by TLC). The solvent was
evaporated under vacuum and the solid residue was dissolved in
dry acetone (20 ml) and the solution was chromatographed on thin
layer plates (silica gel) using toluene. The mobile phases containing
products 3a--e were extracted by acetone. The obtained products were
recrystallised from the stated solvents.
N'-(6-Benzayl-4-phenyl-2H-I, 3-thiazin-2-ylidene)-benzahydrazide
(3a): Yellow crystals (0.66 g, 80%), m.p. 310°C (ethanol). IH NMR
(400 MHz, CDCI3): BH = 8.10-8.0 (dd, 2 H, J = 8.0, 1.0 Hz, ArH),
7.90-7.40 (m, 7 H,ArH), 7.36--7.20 (m, 4 H,ArH), 7.10 (s, 1 H, H-5),
6.90-6.82 (m, 2 H, ArH), 6.60 (s, 1H, NH-N). BC NMR (100.6 MHz,
CDCI3): Be = 186.2 (COPh), 168.0 (CONH), 162.8 (C-4), 158.2
(C-2), 132.0 (C-6), 135.2, 133.8, 130.0 (ph-C), 127.2, 127.0, 126.8
(artha-2Ar CH), 126.4, 126.2, 126.0 (meta-Ar 2CH), 125.6, 125.0,
124.8 (para-Ar CH), 124.2 (CH-5). IR (KBr): vmax = 3320 (m, NH),
3090-3010 (w,Ar-CH), 1700 (s, COPh), 1680 (s, CONH), 1612-1600
(hr, s, C=N), 1590 (m, C=C), 1120 (m, C-S) em-I. A.",ax (CH3CN, 19
e, urn): 360 (3.4). MS (EI): m/z (%) = 411 [M+] (100),335 (22), 306
(24),292 (18), 286 (14), 278 (14), 202 (34), 128 (24), 126 (26), 105
(62), 77 (24). C2JI17N302S (411.49): Calcd C, 70.06; H, 4.16; N,
10.21; S, 7.79%. Found C, 70.20; H, 4.08; N, 10.16; S, 7.71%.
N' -(6-B enzayl-4-phenyl- 2H-I, 3-thiazin- 2-ylidene)-( 4'-hydraxy-
phenyl)hydrazide (3b): Yellow plates (0.71 g, 83%), m.p. 234°C
(ethanol). IH NMR (400 MHz, CDCI3): BH = 9.10 (s, 1 H, OH),
7.90-7.75 (dd, 2 H, J = 8.0, 1.2 Hz, ArH), 7.60-7.42 (m, 6 H,
ArH), 7.30-7.12 (m, 6 H, ArH), 6.98 (s, 1 H, H-5), 6.80 (s, 1 H,
NH-N). BC NMR (100.6 MHz, CDCI3): Be= 186.6 (COPh), 168.4
(CONH), 163.0 (C-4), 158.4 (C-2), 148.8 (OH-Ar-C), 132.4 (C-6),
133.8, 133.6, 133.0 (Ph-C), 128.6, 127.2, 127.0 (artha-2Ar CH),